Avanos Medical
AVNS
260 hedge funds and large institutions have $884M invested in Avanos Medical in 2023 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 70 increasing their positions, 86 reducing their positions, and 40 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.93% less ownership
Funds ownership: 95.07% → 93.14% (-1.9%)
5% less funds holding
Funds holding: 274 → 260 (-14)
19% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 86
22% less capital invested
Capital invested by funds: $1.13B → $884M (-$250M)
28% less call options, than puts
Call options by funds: $38K | Put options by funds: $53K
30% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 40
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
+$24.8M |
| 2 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
+$8.94M |
| 3 |
JGC
J. Goldman & Co
New York
|
+$5.24M |
| 4 |
RC
RGM Capital
Naples,
Florida
|
+$4.28M |
| 5 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$3.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$50.3M |
| 2 |
Goldman Sachs
New York
|
-$5.58M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$4.72M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$4.33M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.06M |
AVNS Hedge Fund Activity: Q3 2023 in Review
260 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q3 2023, worth a combined $884M — down 22% from $1.13B a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of AVNS and 28 opened new positions — a net loss of 12 holders — while 86 trimmed existing stakes and 70 added.
The largest buyer was William Blair Investment Management, opening a new position worth an estimated $24.8M. The largest seller was Macquarie Group, exiting entirely with an estimated $50.3M sold.
- 260 institutional investors held Avanos Medical (AVNS) as of Q3 2023, down from 274 in Q2 2023.
- Funds reported $884M of Avanos Medical stock for Q3 2023, down 22% quarter-over-quarter.
- 28 funds opened new Avanos Medical positions in Q3 2023 and 40 closed out, a net change of -12 holders.
- The largest Avanos Medical buyer in Q3 2023 was William Blair Investment Management, an estimated $24.8M added.
- The largest Avanos Medical seller in Q3 2023 was Macquarie Group, an estimated $50.3M sold.
Based on aggregated 13F filings for Q3 2023.